Dow Up 0.26% Nasdaq Down 1.07%

Genetic Technologies Limited (GENE)

-NasdaqCM
0.55 Down 0.12(18.36%) Sep 15, 3:57PM EDT
Prev Close:0.67
Open:0.60
Bid:0.55 x 1300
Ask:0.60 x 900
1y Target Est:2.50
Beta:-0.63
Next Earnings Date:N/A
Day's Range:0.50 - 0.60
52wk Range:0.50 - 2.49
Volume:428,247
Avg Vol (3m):276,402
Market Cap:11.78M
P/E (ttm):N/A
EPS (ttm):-0.60
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for GENE

Comparison

Symbol% ChgMkt Cap
GENEDown 18.36%11.78M
ABTUp 0.40%64.24B

Key Statistics

Forward P/E (1 yr):27.35
P/S (ttm):3.48
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Jun-15) :-0.18
Quarterly EPS Est (0-00-31) :N/A
Mean Recommendation*:1.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Genetic Technologies Limited provides genetic testing services primarily in Australia and the United States. It offers a range of DNA based genetic tests for cancer predisposition, including breast cancer, ovarian cancer, bowel cancer, and uterine... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback